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Effect of PAG1 on Src-Family Kinase Trafficking in Neuroblastoma Exosomes
Makenzie Mayfield, Lauren Foltz, Jordan Dillon, Madeline Ulmer, Ava Troy and Mark Grimes

Question: Is PAG1 important for trafficking of SFKs into exosomes?
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SRC-family kinases (SFKs) are important in regulating cell-fate in
neuroblastoma cells. PAG1 binds SFKs and helps regulate their
activity by directing their movement within the cell. To better
understand the role of PAG1, we created a line of mutant SHSY5Y cells, called PAG1TM- cells, which express a truncated PAG1
protein that lacks the transmembrane domain. These cells still
express high levels of mutant, cytosolic PAG1. We have found
that PAG1TM- cells exhibit a hyper-cancerous phenotype and have
higher global levels of active phosphorylated SFKs (pSFKs). The
role of pSFKs in PAG1TM- cells is still unclear. Protease protection
experiments suggest that PAG1TM- cells may accumulate more
pSFKs in multivesicular bodies (MVBs), however fractionation
experiments have indicated that pSFKs primarily localize to early
endosome and cytosol fractions.

Exosomes:
Exosomes are small extracellular vesicles (50-100nm in
diameter) that are released by fusion of MVBs with the
plasma membrane. Neuroblastoma cells, including SH-SY5Y
cells, have been shown to release exosomes containing SFKs,
including FYN and LYN. To determine if PAG1 is important for
trafficking of SFKs into exosomes, I isolated exosomes from
both wild-type (WT) and PAG1TM- SH-SY5Y cells to compare
levels of SFKs.
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Increased growth rate in PAG1TM- cells and decreased
sensitivity to PP2. PP2 was used at three different
concentrations to inhibit SFKs. Growth rates were calculated as
the number of doublings per day and compared by calculating
the growth rate index (GRI), a normalized ratio (see methods for
formula). Boxplots show the interquartile range of GRIs
comparing PAG1TM- cells to WT cells (a) or of PP2-treated to
control cells (b) for each concentration of PP2. *P<0.05,
**P<0.005, ***P<0.0005. Student’s t test was also calculated
for pooled growth rates of WT vs. PAG1TM- cells. All P-values
were less than 0.05.
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SFK signaling in neuroblastoma:
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Western blot results of exosomes: Exosomes were isolated from WT and PAG1TM- cells and probed for FYN,
LYN, pSFK and the exosomal marker CD9 (also known as Tetraspanin-29) in a Western blot. To determine the
relative amount of SFKs expressed in exosomes, the SFK signal was divided by the CD9 signal for each
sample. The SFK to CD9 ratio is shown as a percentage of the maximum between WT and PAG1TM- exosomes
(a). Images of the experiment are shown in (b).
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Methods
Proliferation assays:
Five MTT assays were carried out with cells grown for either 2 or 3 days
in different concentrations of PP2 (an SFK inhibitor). Growth rate indices
(GRIs) were calculated for each assay individually with the formula
& ' /&
𝐺𝑅𝐼 = 2
− 1 , where R’ and R represent the number of doublings
per day for experiment and control conditions respectively.
Exosome Isolation by ultracentrifugation:
Conditioned media was collected from cells after incubation for 24
hours. Two spins were done to remove cells, and larger cell fragments:
one at 2,000 x g for 20 minutes, and a second at 5,000 x g for 60
minutes. Exosomes were pelleted from the supernatant by spinning at
40,000rpm for 90 minutes, then dissolved in Urea buffer containing
SDS. Digested exosomes were analyzed by Western blotting.
Cloning and sequencing of LAN6 cells:
LAN6 cells were previously transfected with CRISPR plasmids targeting
exon 5 of the PAG1 gene. Transfected cells were then cloned by limiting
dilution. The targeted region of exon 5 was amplified using PCR prior to
sequencing.

• PAG1TM- cells proliferate faster than
WT cells.
• Proliferation in PAG1TM- cells is less
sensitive to SFK inhibition by PP2
than proliferation in WT cells.
• PAG1TM- mutation caused
decreased levels of total pSFKs and
LYN incorporated into exosomes,
but had minimal effect on FYN in
SH-SY5Y cells.
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LAN6 PAG1 TM-

Allele 1- T insertion
Wild-type:

126 GGAAAAGAAGCCGCGACAGCATAGTGGGGACCATGAGAACCTGATGAACGTG 177
--E--K--K--P--R--Q--H--S--G--D--H--E--N--L--M--N--VClone 14:
LAN6 PAG1 TM-

126 GGAAAAGAAGCCGCGACAGCATAAGTGGGGACCATGA 170
--E--K--K--P--R--Q--H--K--W--G--P-stop
Allele 2- Frameshift deletion
Wild-type:

126 GGAAAAGAAGCCGCGACAGCATAGTGGGGACCATGA 161
Clone 14:

126 GGAAAAGAAGCCCCATGA 155
-E--K--K--P--P-stop

PAG1TM- LAN6 mutants: . LAN6 cells, another neuroblastoma cell-line, have a slower growing and less differentiated phenotype compared to SHSY5Y cells. The same PAG1TM- mutation was attempted in LAN6 cells. Several clones were isolated and sequenced. Clones 14 and 32 were identified
as heterozygous mutants, with mutations in both copies of exon 5. Sequencing results for clone 14 are shown above. Unfortunately, we have been
unable to verify a mutant phenotype due to difficulty detecting the protein.

• PAG1TM- mutation increases
proliferation in SH-SY5Y cells.
TM• Increased proliferation in PAG1
cells is not affected by
concentrations of SFK inhibitors
that inhibit proliferation in WT
cells.
• Membrane-bound PAG1 is required
for incorporation of pSFKs and LYN
into exosomes.

Questions for future directions
• Are SFKs effectively inhibited by PP2 in
PAG1TM- cells?
• Are increased levels of pSFKs important
for proliferation in PAG1TM- cells?
• Does PAG1TM- bind SFKs in the cytosol and
interfere with targeting of SFKs?
• Does PAG1TM- prevent pSFKs from
reaching MVBs, resulting in diminished
release of pSFKs in exosomes?
• Alternatively, are pSFKS in MVBs recycled
back to the cytosol or degraded in
lysosomes?
• Is PAG1 exported into exosomes along
with SFKs in WT cells?
• Is PAG1 required to escort SFKs into
exosomes?

